by Luo, W. et al.
Institute of Molecular Immunology, School of Biotechnology, Southern Medical University, Guangzhou 510515, China
Institute of Molecular Immunology, School of Biotechnology, Southern Medical University, Guangzhou 510515, China
Dynamic monitoring the TCR CDR3 spectratypes in patients with metastatic CRC treated with a combination of bevacizumab, irinotecan, fluorouracil, and leucovorin.
Cancer Immunol. Immunother. 2010; 2:247-56
